257 related articles for article (PubMed ID: 27919787)
1. Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
Garg B; Giri B; Majumder K; Dudeja V; Banerjee S; Saluja A
Cancer Lett; 2017 Mar; 388():64-72. PubMed ID: 27919787
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
3. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
Lettini G; Condelli V; Pietrafesa M; Crispo F; Zoppoli P; Maddalena F; Laurenzana I; Sgambato A; Esposito F; Landriscina M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065966
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
5. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
[TBL] [Abstract][Full Text] [Related]
6. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
[TBL] [Abstract][Full Text] [Related]
7. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
[TBL] [Abstract][Full Text] [Related]
8. Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.
Morrow KA; Das S; Meng E; Menezes ME; Bailey SK; Metge BJ; Buchsbaum DJ; Samant RS; Shevde LA
Oncotarget; 2016 Apr; 7(14):17991-8005. PubMed ID: 26908451
[TBL] [Abstract][Full Text] [Related]
9. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
10. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
[TBL] [Abstract][Full Text] [Related]
11. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-4 inhibits Wnt/β-catenin signaling through regulation of low-density-lipoprotein receptor-related protein (LRP6) and R-spondin 3.
Astudillo P; Carrasco H; Larraín J
Int J Biochem Cell Biol; 2014 Jan; 46():103-12. PubMed ID: 24275095
[TBL] [Abstract][Full Text] [Related]
13. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.
Reinke L; Lam AP; Flozak AS; Varga J; Gottardi CJ
Biochem Biophys Res Commun; 2016 Feb; 470(3):606-612. PubMed ID: 26797284
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling.
Liang J; Liu Y; Zhang L; Tan J; Li E; Li F
Chem Biol Interact; 2019 May; 304():1-9. PubMed ID: 30831090
[TBL] [Abstract][Full Text] [Related]
17.
Xu R; Wang X; Safi S; Braunegger N; Hipgrave Ederveen A; Rottmann M; Wittbrodt J; Wuhrer M; Wesslowski J; Davidson G
Cells; 2023 Mar; 12(6):. PubMed ID: 36980204
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
19. Waif1/5T4 inhibits Wnt/β-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization.
Kagermeier-Schenk B; Wehner D; Ozhan-Kizil G; Yamamoto H; Li J; Kirchner K; Hoffmann C; Stern P; Kikuchi A; Schambony A; Weidinger G
Dev Cell; 2011 Dec; 21(6):1129-43. PubMed ID: 22100263
[TBL] [Abstract][Full Text] [Related]
20. In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling.
Hong S; Feng L; Yang Y; Jiang H; Hou X; Guo P; Marlow FL; Stanley P; Wu P
Cell Chem Biol; 2020 Sep; 27(9):1140-1150.e4. PubMed ID: 32649905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]